Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History $2.15 -0.05 (-2.27%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.15 +0.00 (+0.23%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Oramed Pharmaceuticals Stock Price Performance 5 Day Performance+1.90%1 Month Performance-10.42%3 Month Performance-5.70%6 Month Performance-7.13%Year-To-Date Performance-11.16%1 Year Performance-2.27% Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ORMP Stock Chart for Friday, April, 18, 2025 ORMP Chart by TradingView Oramed Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/17/2025$2.20$2.15-2.27%$2.24$2.1535,166 shs$87.83 million04/16/2025$2.23$2.20-1.35%$2.24$2.1422,994 shs$89.87 million04/15/2025$2.27$2.23-1.76%$2.29$2.2134,691 shs$91.10 million04/14/2025$2.11$2.27+7.58%$2.30$2.20118,026 shs$92.73 million04/11/2025$2.13$2.11-0.94%$2.15$2.0994,343 shs$86.19 million04/10/2025$2.12$2.13+0.47%$2.13$2.0153,680 shs$87.01 million04/09/2025$2.03$2.12+4.43%$2.21$1.82258,526 shs$86.60 million04/09/2025$2.03$2.12+4.43%$2.21$1.82258,526 shs$86.60 million04/08/2025$2.10$2.03-3.33%$2.26$2.03102,157 shs$82.93 million04/08/2025$2.10$2.03-3.33%$2.26$2.03102,157 shs$82.93 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/07/2025$2.10$2.10$2.12$2.0462,970 shs$85.79 million04/04/2025$2.16$2.10-2.78%$2.19$2.06102,058 shs$85.79 million04/03/2025$2.20$2.16-1.82%$2.37$2.12154,779 shs$88.24 million04/02/2025$2.13$2.20+3.29%$2.20$2.1163,816 shs$88.69 million04/01/2025$2.14$2.13-0.47%$2.16$2.0691,211 shs$85.87 million03/31/2025$2.21$2.14-3.17%$2.23$2.08110,089 shs$86.27 million03/28/2025$2.30$2.21-3.91%$2.32$2.1874,075 shs$89.09 million03/27/2025$2.36$2.30-2.54%$2.40$2.3039,036 shs$92.72 million03/26/2025$2.33$2.36+1.29%$2.38$2.3048,464 shs$95.14 million03/25/2025$2.34$2.33-0.43%$2.39$2.3130,850 shs$93.93 million03/24/2025$2.33$2.34+0.43%$2.36$2.3118,307 shs$94.33 million03/21/2025$2.37$2.33-1.69%$2.39$2.3116,866 shs$93.93 million03/20/2025$2.35$2.37+0.85%$2.41$2.3422,882 shs$95.54 million03/19/2025$2.40$2.35-2.08%$2.42$2.3226,379 shs$94.73 million03/18/2025$2.37$2.40+1.27%$2.46$2.3750,291 shs$96.75 million03/17/2025$2.39$2.37-0.84%$2.40$2.3643,141 shs$95.54 million Related Companies Eton Pharmaceuticals Stock Chart Verve Therapeutics Stock Chart ORIC Pharmaceuticals Stock Chart Tourmaline Bio Stock Chart Kamada Stock Chart Rapport Therapeutics Stock Chart Altimmune Stock Chart Autolus Therapeutics Stock Chart Erasca Stock Chart SNDL Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
